Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region

Radwa Ahmed Batran,Mohab Kamel,Ayman Bahr,Joseph Waheb,Ahmed Khalil,Mohamed Elsokary
DOI: https://doi.org/10.1080/14737167.2024.2364832
2024-06-09
Expert Review of Pharmacoeconomics & Outcomes Research
Abstract:Introduction Multiple sclerosis (MS) is a persistent condition characterized by immune-mediated processes in the central nervous system, affecting around 2.8 million individuals globally. While historically less prevalent in the Middle East and North Africa (MENA) region, recent trends mirror the global rise in MS.
pharmacology & pharmacy,health care sciences & services,health policy & services
What problem does this paper attempt to address?